MILLENNIUM MANAGEMENT LLC
Position in SUPN — Supernus Pharmaceuticals, Inc.
CIK 1273087
NEW YORK, NY
Position in SUPN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$171,402,644
+$40,191,364 QoQ
Shares Held
3,315,973
+25.6% QoQ
Ownership
5.71%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Derivatives in SUPN
reported options exposure · as of Dec 31, 2025CallValue
$2,236,500
CallShares
45,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026MILLENNIUM MANAGEMENT LLC holds $1,131,904,343 across 44 Drug Manufacturers - Specialty & Generic names. SUPN ranks #2 (15.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,649,955 | $195,041,180 | |
| 2 | SUPN |
Supernus Pharmaceuticals, Inc.
This page
|
3,315,973 | $171,402,644 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
1,247,447 | $164,338,667 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
4,595,535 | $140,071,906 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
153,372 | $90,946,528 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,893,845 | $57,042,611 | |
| 7 | PRGO |
PERRIGO Co plc
|
4,279,731 | $45,964,310 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
592,013 | $45,525,799 |
All Filings in SUPN
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $171,402,644 | 3,315,973 | Shares | Sole | 2026-05-15 | |
| 2026-02-11 | $168,478,114 | 3,281,615 | Shares | Sole | 2026-02-18 | |
| 2026-01-26 | $149,255,806 | 3,036,123 | Shares | Sole | 2026-02-02 | |
| 2025-12-31 | $2,236,500 | 45,000 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $131,211,280 | 2,640,066 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $16,549,342 | 346,293 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $9,887,751 | 206,900 | Call | Sole | 2025-11-14 | |
| 2025-06-30 | $412,060 | 13,073 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,694,909 | 143,356 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,101,795 | 30,470 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,880,526 | 252,743 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,315,631 | 161,332 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,111,610 | 32,589 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $5,052,576 | 174,588 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,156,111 | 78,205 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,012,258 | 133,475 | Shares | Sole | 2023-08-14 | |
| 2023-06-30 | $1,803,600 | 60,000 | Call | Sole | 2023-08-14 | |
| 2023-03-31 | $1,811,500 | 50,000 | Call | Sole | 2023-05-15 | |
| 2023-03-31 | $1,033,895 | 28,537 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $16,174,490 | 453,448 | Shares | Sole | 2023-02-14 | |
| 2022-06-30 | $7,062,929 | 244,223 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $2,672,863 | 91,662 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $11,135,365 | 417,524 | Shares | Sole | 2021-11-15 | |
| 2021-09-30 | $266,700 | 10,000 | Call | Sole | 2021-11-15 | |
| 2021-06-30 | $3,228,177 | 104,845 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $537,527 | 20,532 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $222,892 | 8,859 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $224,842 | 10,789 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $717,131 | 30,195 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||